Table content
**Sources Indicate White House Could Revoke Automotive and Semiconductor Levies on April 2**
*Released: March 24, 2025*
*7:27 AM ET*
**Principal Conclusions:**
* It is being said that the White House is diminishing its levy strategies that are scheduled to become effective on April 2. Specific levies on divisions such as vehicles, medications, and microchips might not be declared.
* The Wall Street Journal states that corresponding duties on objective nations will still be activated on April 2. Although, duties on crucial businesses might be removed from consideration.
* Bloomberg was the first to state that President Trump is intending a more concentrated levy declaration on April 2, reducing prior intimidations.
The White House is obviously reconsidering its method to duties planned for April 2. Informants propose that definite duties on businesses such as vehicles, medication, and semiconductors are improbable to be revealed.
Quoting a government representative and persons acquainted with the subject, The Wall Street Journal stated Sunday that corresponding duties on aimed countries are still scheduled to commence on April 2. Nevertheless, the WSJ indicated that duties on divisions such as medications, cars, and semiconductors might not be incorporated in the initial declaration.
The report expressed, “The administration is presently concentrating on imposing duties on approximately 15% of countries with which the United States has a consistent trade shortfall.” Toncoin (TON) Value Forecast for March 26th
Bloomberg News originally stated that President Trump intends to declare more objective duties in his April 2 statement, a divergence from earlier, wider intimidations.
The White House has not yet answered requests for observation.
Certainly, we will reinforce our efforts with reliable investigation from additional dependable origins whenever it is reasonable. Should you be inquisitive regarding our process to guarantee the impartiality, precision, and reliability of our publications, you can delve into our editorial guidelines for comprehensive specifics.